CHOSA — Chosa Oncology AB Income Statement
0.000.00%
Last trade - 00:00
- SEK64.74m
- SEK55.97m
- SEK0.07m
R2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | Interim Report | PRESS |
Standards: | SAS | SAS | SAS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 5.98 | 6.01 | 10.2 | 4.08 | 0.073 |
Selling / General / Administrative Expenses | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 42.5 | 53.5 | 72 | 45.4 | 23.6 |
Operating Profit | -36.5 | -47.5 | -61.9 | -41.3 | -23.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -38.3 | -47.9 | -62.1 | -41.3 | -23.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -34.5 | -40.2 | -54.6 | -33.4 | -23.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -34.5 | -40.2 | -54.6 | -33.4 | -23.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -34.5 | -40.2 | -54.6 | -33.4 | -23.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.49 | -2.11 | -2.87 | -1.75 | -0.37 |
Dividends per Share |